NICOX (EPA:COX) | WebDisclosure

Basculer en Français

10816	Companies
234404	Keywords
163259	Articles
125410	Press releases

Home
Companies
NICOX

PRESS RELEASE

published on 06/06/2025 at 07:30, 1 year 2 months ago

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representative
Nicox SA announces Ordinary and Extraordinary Shareholders' Meeting on June 27, 2025, appoints ad hoc representative. Details on agenda, proxy voting, and meeting participation

Shareholders' Meeting Proxy Voting Nicox SA Ad Hoc Representative Meeting Participation
PRESS RELEASE

published on 06/06/2025 at 07:30, 1 year 2 months ago

Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 27 juin 2025 et désignation d’un mandataire ad hoc
Nicox convoque une Assemblée Générale Ordinaire et Extraordinaire le 27 juin 2025, avec un mandataire ad hoc pour représenter les actionnaires défaillants

Actionnaires Assemblée Générale Ophtalmologie Nicox Mandataire Ad Hoc
BRIEF

published on 05/27/2025 at 07:35, 1 year 2 months ago

Nicox obtient jusqu'à 3 millions d'euros grâce à Kowa pour l'avancée de NCX 470

Phase 3 Nicox Hypertension Oculaire NCX 470 Kowa
BRIEF

published on 05/27/2025 at 07:35, 1 year 2 months ago

Nicox secures up to €3 million from Kowa to advance NCX 470

Ocular Hypertension Phase 3 Nicox NCX 470 Kowa
PRESS RELEASE

published on 05/27/2025 at 07:30, 1 year 2 months ago

Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025, alors que NCX 470 se prépare à entrer en essais cliniques de Phase 3 au Japon
Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025 pour le lancement d'essais cliniques de Phase 3 de NCX 470 au Japon, prolongeant ainsi leur horizon de trésorerie

Essais Cliniques Nicox Horizon De Trésorerie Kowa Paiements D'étapes
BRIEF

published on 05/14/2025 at 07:35, 1 year 2 months ago

Nicox Reports Findings from Whistler Phase 3b Glaucoma Trial

Glaucoma Nicox NCX 470 Whistler Phase 3b Intraocular Pressure
BRIEF

published on 05/14/2025 at 07:35, 1 year 2 months ago

Nicox publie les résultats de l'essai de phase 3b sur le glaucome à Whistler

Nicox NCX 470 Glaucome Whistler Phase 3b Pression Intraoculaire
PRESS RELEASE

published on 05/14/2025 at 07:30, 1 year 2 months ago

Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial
Nicox announces positive results of Whistler Phase 3b glaucoma trial with NCX 470 showing efficacy in lowering intraocular pressure via dual mechanism action of nitric oxide and prostaglandin analogs. Safety profile consistent with previous trial

Nicox NCX 470 Glaucoma Trial Whistler Phase 3b Intraocular Pressure
BRIEF

published on 04/30/2025 at 07:35, 1 year 3 months ago

Nicox Reports Full Year 2024 Financials

Net Loss Cash Reserves Nicox Financial Results VYZULTA Revenue Sale NCX 470 Trials
BRIEF

published on 04/30/2025 at 07:35, 1 year 3 months ago

Nicox publie ses résultats financiers pour l'année 2024

Perte Nette Réserves De Trésorerie Résultats Financiers De Nicox Vente De Revenus De VYZULTA Essais NCX 470

Accesswire

Published on 08/10/2026 at 15:30, 4 hours 59 minutes ago

Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 5 hours 4 minutes ago

Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 5 hours 59 minutes ago

NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Published on 08/10/2026 at 13:30, 6 hours 59 minutes ago

Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Published on 08/10/2026 at 13:00, 7 hours 29 minutes ago

Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada

View all ACCESSWIRE

EQS Group

Published on 08/10/2026 at 19:35, 54 minutes ago

Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 19:00, 1 hour 29 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 03 AOUT 2026 au 07 AOUT 2026
Published on 08/10/2026 at 18:29, 1 hour 59 minutes ago

Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 08/10/2026 at 17:50, 2 hours 39 minutes ago

Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Published on 08/10/2026 at 17:38, 2 hours 51 minutes ago

PATRIZIA delivers strong earnings growth with EUR 42.7m EBITDA (+46.6% y-o-y) in H1 2026

Les Echos

Published on 08/10/2026 at 18:00, 2 hours 29 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 hours 29 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 hours 44 minutes ago

Weekly share buyback
Published on 08/10/2026 at 17:45, 2 hours 44 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 8 hours 35 minutes ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

View all LES ECHOS COMFI WIRE